文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在中国浙江省,肌肉减少症与非酒精性脂肪肝的存在有关:一项横断面观察性研究。

Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.

机构信息

Department of Geriatrics, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.

Zhejiang Provincial Key Laboratory for Diagnosis and Treatment of Aging and Physic-chemical Injury Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.

出版信息

BMC Geriatr. 2021 Jan 14;21(1):55. doi: 10.1186/s12877-020-01910-3.


DOI:10.1186/s12877-020-01910-3
PMID:33446095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807816/
Abstract

BACKGROUND: Currently, both non-alcoholic fatty liver disease (NAFLD) and sarcopenia have attracted extensive attention in public health. However, the relationship between NAFLD and sarcopenia remains unclear. This study aimed to clarify the sex-specific association between sarcopenia and NAFLD according to the Asian Working Group for Sarcopenia (AWGS). METHODS: Dual-energy X-ray absorptiometry (DXA) and hepatic ultrasonography were measured in 578 participants (92 men and 486 women) during their annual health examinations. Multivariate logistic regression models were used to explore the association between NAFLD and sarcopenia with its two components. RESULTS: A total of 154 participants (30 men and 124 women) had NAFLD. The prevalence of sarcopenia was higher among the participants with NAFLD than among those without NAFLD (men: 20.0% vs. 9.7%, P = 0.295, women: 15.3% vs. 8.0%, P = 0.019). Low muscle mass (LMM) was independently associated with NAFLD in both men and women (men: odds ratio [OR], 2.88; 95% confidence interval [CI] 1.52-5.46; women: OR, 2.08; 95% CI 1.63-2.67). However, low muscle strength (LMS) was independently associated with NAFLD only in male participants, with an OR of 1.15 (95% CI 1.02-1.28). CONCLUSION: The occurrence of sarcopenia was associated with a higher risk of NAFLD, especially in men, as demonstrated by lower muscle mass and lower muscle strength.

摘要

背景:目前,非酒精性脂肪性肝病(NAFLD)和肌少症均受到公众健康的广泛关注。然而,NAFLD 和肌少症之间的关系尚不清楚。本研究旨在根据亚洲肌少症工作组(AWGS)阐明肌少症与 NAFLD 之间的性别特异性关联。

方法:在年度健康检查中,使用双能 X 射线吸收法(DXA)和肝脏超声测量了 578 名参与者(92 名男性和 486 名女性)的数据。使用多变量逻辑回归模型探讨了 NAFLD 与肌少症及其两个组成部分之间的关系。

结果:共有 154 名参与者(30 名男性和 124 名女性)患有 NAFLD。患有 NAFLD 的参与者中肌少症的患病率高于未患有 NAFLD 的参与者(男性:20.0%比 9.7%,P=0.295,女性:15.3%比 8.0%,P=0.019)。低肌肉量(LMM)与男性和女性的 NAFLD 均独立相关(男性:比值比[OR],2.88;95%置信区间[CI],1.52-5.46;女性:OR,2.08;95%CI,1.63-2.67)。然而,低肌肉力量(LMS)仅与男性参与者的 NAFLD 独立相关,其 OR 为 1.15(95%CI,1.02-1.28)。

结论:肌少症的发生与 NAFLD 的风险增加相关,尤其是在男性中,表现为肌肉量和肌肉力量降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/5f968b993446/12877_2020_1910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/5f968b993446/12877_2020_1910_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/7807816/7b335902bbac/12877_2020_1910_Fig2_HTML.jpg

相似文献

[1]
Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.

BMC Geriatr. 2021-1-14

[2]
The Relationship between NAFLD and Sarcopenia in Elderly Patients.

Can J Gastroenterol Hepatol. 2018-3-26

[3]
Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.

Calcif Tissue Int. 2024-6

[4]
Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.

Clin Nutr. 2020-4

[5]
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.

Hepatobiliary Pancreat Dis Int. 2016-2

[6]
Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).

Int J Chron Obstruct Pulmon Dis. 2020

[7]
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.

Am J Gastroenterol. 2020-4

[8]
Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.

Hepatol Int. 2022-6

[9]
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.

J Bone Miner Res. 2019-5-10

[10]
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.

Diabetes Metab. 2020-10

引用本文的文献

[1]
Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia.

Int J Mol Sci. 2025-5-14

[2]
Efficiency of Skeletal Muscle Mass/Weight Measurement for Distinguishing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Analysis Using InBody Bioimpedance Devices.

Nutrients. 2024-12-23

[3]
Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review.

Obes Facts. 2025

[4]
Serum Creatinine as an Independent Predictor of Moderate to Severe Fibrosis in Chinese American Non-obese Metabolic Dysfunction-Associated Steatotic Liver Disease.

Cureus. 2024-5-26

[5]
The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review.

J ASEAN Fed Endocr Soc. 2024

[6]
Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.

J Nutr Health Aging. 2024-6

[7]
Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis.

BMJ Open. 2024-5-6

[8]
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease.

World J Gastrointest Pathophysiol. 2024-4-22

[9]
Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.

Calcif Tissue Int. 2024-6

[10]
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease.

World J Gastroenterol. 2024-2-21

本文引用的文献

[1]
Defining sarcopenia: some caveats and challenges.

Curr Opin Clin Nutr Metab Care. 2020-3

[2]
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.

Diabetes Metab. 2020-10

[3]
Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study.

Aging (Albany NY). 2019-7-7

[4]
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.

J Bone Miner Res. 2019-5-10

[5]
Aerobic capacity and exercise performance in nonalcoholic fatty liver disease.

J Sports Med Phys Fitness. 2019-8

[6]
Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing.

J Epidemiol Community Health. 2018-10-27

[7]
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Nat Rev Endocrinol. 2018-9

[8]
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.

Hepatology. 2018-10-14

[9]
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).

Medicine (Baltimore). 2018-3

[10]
Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

Liver Int. 2018-3-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索